There's no shortage of mobile apps being produced by pharmaceutical companies and this roundup selects three of the most recent entrants to the market.

First up, and seemingly taking its cue from Google's erstwhile body browser, GE Healthcare has put 3D interactive models of the human body online.

Produced in partnership with Healthline Networks, the Healthline Body Maps iPad app costs up to £10.49 (just over €13) and is aimed at practicing clinicians and students.

Meanwhile the service is also available via a website, which aims to patients a learning tool for use before, during or after they visit the doctor, with the ultimate goal of helping to improve consumers' health literacy.

“The more people understand their bodies, the more proactive they become in managing their care and making informed treatment decisions,” the company explained.

The website has male and female version of 28 organs and systems and matches “consumer-friendly anatomical terms with easy-to-read articles.

- - - -

Swedish Orphan Biovitrum has launched an iPhone and iPad app for patients who suffer from the rare genetic condition hereditary angioedema (HAE) to help them record and manage their attacks.

The free HAELP app allows users to log the time and duration of their attacks through a patient diary function and has an interactive map of European HAE centres and information on the condition in 12 European languages.

The company says it is also hard at work developing an Android version of the app.

- - - -

US generic company Mylan has put its printed Generic Brand Reference guide for US healthcare professionals, patients and pharmacy students into app form.

Only available so far for Apple's iPhone, iPod touch and iPad, the free Mylan GBR Guide app gives brand and generic product names, and offers clinical support tools such as laboratory reference values and an interactive medical abbreviations converter.

• Details of more mobile apps from pharma are available in the Digital Handbook

Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more